Apic Bio
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Antitrypsin Deficiency, genetic ALS, and other CNS conditions.
est. 2017
Solid Biosciences is the older company (2017 vs 2013).
Side-by-Side Comparison
| Metric | Apic Bio | Solid Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2013 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Boston, United States |
| Employees | ||
| Employees | Not tracked yet | 161 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $53.32M | $610.30M |
| Funding Rounds | ||
| Funding Rounds | 3 | 9 |
| Services | ||
| Services | Not tracked yet | Gene Therapy Development, Clinical Trials, Research Collaborations, Licensing Opportunities, Manufacturing Infrastructure |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Rare Neuromuscular Diseases, Patients with Cardiac Diseases, Medical Researchers, Healthcare Providers, Biotechnology Collaborators |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Rare Diseases, Neurological Disorders, Liver Diseases, Alpha-1 Antitrypsin Deficiency, ALS, Central Nervous System Disorders, Treatment Options, Pioneering Therapies, Medical Innovation | Precision Genetic Medicine, Gene Therapy, Rare Neuromuscular Diseases, Cardiac Diseases, Duchenne Muscular Dystrophy, Friedreich’s Ataxia, Catecholaminergic Polymorphic Ventricular Tachycardia, Dilated Cardiomyopathy, Genetic Regulators, Gene Therapy Delivery, Dystrophin Protein Restoration, Orphan Drug Designation, Rare Pediatric Disease Designation, Preclinical Program, Phase I/II Clinical Trial |
| Website | ||
| Website | apic-bio.com | solidbio.com |
About Apic Bio
Apic Bio is a biotechnology startup founded in 2017 with a focus on pioneering gene therapies for rare neurological and liver diseases. The company's mission is to address underserved medical conditions, including Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS),...
About Solid Biosciences
Solid Biosciences, founded in 2013 and headquartered in Charlestown, MA, USA, is a trailblazer in the biotechnology sector, especially in precision genetic medicine. Their motto, #TogetherWeAreSolid, reflects their commitment to advancing gene therapy solutions for rare neuromuscular and cardiac dis...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Apic Bio and Solid Biosciences — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Apic Bio and Solid Biosciences — by email.
Frequently Asked Questions
Compare Apic Bio with someone else
Start typing a company name or domain.